Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona M Russell

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
The Lancet. Infectious Diseases|January 13, 2019
Pneumococcal vaccines in NepalFiona M Russell, Kim Mulholland
Human Vaccines & Immunotherapeutics|November 3, 2020
Who should be prioritised for COVID-19 vaccination?Fiona M Russell, Brian Greenwood
The Lancet. Infectious Diseases|February 4, 2024
Will two doses of pneumococcal conjugate vaccine be enough?Fiona M Russell, Kulkanya Chokephaibulkit
International Journal of Molecular Sciences|December 30, 2020
AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?Fiona M Russell, David Grahame Hardie
Annals of Tropical Paediatrics|February 22, 2005
Recent advances in pneumococcal vaccination of childrenFiona M Russell, E K Mulholland
The New England Journal of Medicine|August 17, 2023
Lifting Universal School Masking - Covid-19 Incidence among Students and StaffFiona M Russell, Nigel Curtis, John Carlin
The Lancet. Infectious Diseases|January 11, 2025
Mass doses of fractional pneumococcal vaccine in humanitarian settingsFiona M Russell, Kim Mulholland, Leith Greenslade
Bulletin of the World Health Organization|July 12, 2003
Evidence on the use of paracetamol in febrile childrenFiona M Russell, Frank Shann, Nigel Curtis, et al.
The Biochemical Journal|April 9, 2024
AMP-activated protein kinase can be allosterically activated by ADP but AMP remains the key activating ligandSimon A Hawley, Fiona M Russell, D Grahame Hardie
Open Biology|July 11, 2019
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde? <sup>†</sup>Diana Vara-Ciruelos, Fiona M Russell, D Grahame Hardie
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
The Lancet. Infectious Diseases|January 13, 2019
Pneumococcal vaccines in NepalFiona M Russell, Kim Mulholland
Human Vaccines & Immunotherapeutics|November 3, 2020
Who should be prioritised for COVID-19 vaccination?Fiona M Russell, Brian Greenwood
The Lancet. Infectious Diseases|February 4, 2024
Will two doses of pneumococcal conjugate vaccine be enough?Fiona M Russell, Kulkanya Chokephaibulkit
International Journal of Molecular Sciences|December 30, 2020
AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?Fiona M Russell, David Grahame Hardie
Annals of Tropical Paediatrics|February 22, 2005
Recent advances in pneumococcal vaccination of childrenFiona M Russell, E K Mulholland
The New England Journal of Medicine|August 17, 2023
Lifting Universal School Masking - Covid-19 Incidence among Students and StaffFiona M Russell, Nigel Curtis, John Carlin
The Lancet. Infectious Diseases|January 11, 2025
Mass doses of fractional pneumococcal vaccine in humanitarian settingsFiona M Russell, Kim Mulholland, Leith Greenslade
Bulletin of the World Health Organization|July 12, 2003
Evidence on the use of paracetamol in febrile childrenFiona M Russell, Frank Shann, Nigel Curtis, et al.
The Biochemical Journal|April 9, 2024
AMP-activated protein kinase can be allosterically activated by ADP but AMP remains the key activating ligandSimon A Hawley, Fiona M Russell, D Grahame Hardie
Open Biology|July 11, 2019
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde? <sup>†</sup>Diana Vara-Ciruelos, Fiona M Russell, D Grahame Hardie
Pageof 11